ALZINOVA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.21 SEK | +3.42% |
|
+2.54% | -60.13% |
| 06-18 | Alzinova AB Announces All Patients Have Been Recruited in the High-Dose Part of Alzinova's Phase 1B Study | CI |
| 06-10 | Alzinova AB Announces New External Safety Review for Phase 1b Study | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALZINOVA AB | Other Biotechnology & Medical Research | +3.42% | +2.54% | -60.13% | -60.33% | -89.34% | 5.08M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ALZ Stock
- Charts Alzinova AB
- Comparison Chart
